Previous studies also investigate the prognostic value of TRPC1 in a series of solid carcinomas: TRPC1 is correlated with poorer prognosis in patients with breast cancer, colorectal cancer, and gastric cancer.14, 15, 17, 18. This evidence concerns the gene TRPC1 and breast carcinoma.